New hope for vitiligo: which cream boosts light therapy best?
NCT ID NCT07532330
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a tacrolimus or tyrosine cream to standard UVB light therapy helps restore skin color in adults with vitiligo. About 67 participants will receive both creams on different patches and be followed for 3 months. The goal is to see which combination leads to more repigmentation and has fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Minia Tertiary University Hospital, Faculty of Medicine, Minia University, Minia, Egypt.
Minya, Minya Governorate, 61519, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New ointment aims to restore skin color in vitiligo
- Skin microbes linked to vitiligo and immunotherapy reactions in melanoma patients
- New vitiligo registry aims to uncover disease trends in 2,500 patients
- Scientists probe immune secrets of four skin diseases
- Lamp vs laser: which light works best for vitiligo?
- New shot plus light therapy aims to restore skin color in vitiligo